miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3
Authors
Keywords
-
Journal
Cancer Management and Research
Volume Volume 12, Issue -, Pages 5419-5429
Publisher
Informa UK Limited
Online
2020-07-06
DOI
10.2147/cmar.s255125
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NLRP3 Promotes Colorectal Cancer Cell Proliferation and Metastasis via Regulating Epithelial Mesenchymal Transformation
- (2020) Xinyu Shao et al. Anti-Cancer Agents in Medicinal Chemistry
- Pretreatment with a Heat-Killed Probiotic Modulates the NLRP3 Inflammasome and Attenuates Colitis-Associated Colorectal Cancer in Mice
- (2019) I-Che Chung et al. Nutrients
- MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies
- (2019) Gulcin Tezcan et al. Frontiers in Pharmacology
- MicroRNA-22 suppresses cell proliferation, migration and invasion in oral squamous cell carcinoma by targeting NLRP3
- (2018) Xiaodong Feng et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer
- (2018) Yanqing Liu et al. Molecular Cancer
- MicroRNA‑22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells
- (2018) Xiang Zhou et al. Molecular Medicine Reports
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
- (2018) Jacob O'Brien et al. Frontiers in Endocrinology
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis
- (2017) S Li et al. ONCOGENE
- Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation
- (2017) John Nixon et al. PHARMACOLOGY & THERAPEUTICS
- The Challenges of Colorectal Cancer Survivorship
- (2017) Crystal S. Denlinger et al. Journal of the National Comprehensive Cancer Network
- Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis
- (2016) S. Robert et al. BIOSCIENCE REPORTS
- Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review)
- (2016) Jingyu Wang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma
- (2016) Xiang Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges
- (2015) Huiyin Lan et al. Biomed Research International
- MicroRNAs and other non-coding RNAs as targets for anticancer drug development
- (2013) Hui Ling et al. NATURE REVIEWS DRUG DISCOVERY
- Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants
- (2012) Colleen Olive Expert Review of Vaccines
- The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
- (2011) Beckley K. Davis et al. Annual Review of Immunology
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started